Rafferty Asset Management’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.08M | Sell |
46,929
-9,350
| -17% | -$216K | ﹤0.01% | 750 |
|
2025
Q1 | $1.52M | Buy |
56,279
+4,111
| +8% | +$111K | 0.01% | 649 |
|
2024
Q4 | $2.79M | Sell |
52,168
-13,522
| -21% | -$724K | 0.01% | 546 |
|
2024
Q3 | $2.98M | Sell |
65,690
-11,556
| -15% | -$525K | 0.01% | 538 |
|
2024
Q2 | $3.24M | Buy |
+77,246
| New | +$3.24M | 0.01% | 512 |
|